NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as "gene scissors," ...
Researchers engineered a CRISPR base editor to correct the ACTA2 mutation causing multisystemic smooth muscle dysfunction ...
A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...
The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.
Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently, there is no effective treatment or ...
The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases ...
A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...
CRISPR: Is The Selloff Really Over? I guess that's what biotech investors should be familiar with, as the stock of CRISPR Therapeutics AG (CRSP) has truly undergone a roller coaster ride all year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback